Tom von Gunden
Chief Editor Tom von Gunden provides the Drug Delivery Leader audience with indispensable resources for staying current on the drug and biologics delivery industry’s most innovative thinking. In addition to offering his written commentary and moderating events, Tom hosts multiple videocast series in which he and his guests illuminate challenges and advances in delivering medicines and therapies to an ever-widening landscape of patient needs and targets.
ARTICLES BY TOM VON GUNDEN
-
![Halozyme patient panel]( "What Do Patients Appreciate? Therapeutic Innovation And Accessibility")
11/11/2025At the PODD 2025 conference, patient advocates telling their own treatment stories focused on innovations in therapies and delivery methods for targeting chronic and rare diseases, leveraging technologies such as gene editing and subcutaneous delivery of complex biologics. In this article, Chief Editor Tom von Gunden carries forward the patient-centric themes of convenience and accessibility.
